# Patent

## Title
Method for altering the differentiation of anchorage dependent cells on

## Abstract

Plants, particularly transgenic plants, may be produced having a 2-acyltransferase enzyme or other insoluble acyltransferase enzyme with an altered substrate specificity compared to the native enzyme. For example, oil seed rape (Brassica napus) may contain a 2-acyltransferase transgene derived from Limnanthes douglassi in order to increase the erucic acid content of the oil. The cDNA sequence of maize (Zea mays) 2-acyltansferase is disclosed and is useful for cloning acyltransferase genes and/or cDNAs from other organisms, including L. douglassi.

## Background
This invention relates to modified plants. In particular, the invention relates to plants modified such that at least part of the plant (for example seeds of the plant) is capable of yielding a commercially useful oil.

Plants have long been a commercially valuable source of oil. Nutritional uses of plant-derived oils have hitherto been dominant, but attention is now turning additionally to plants as a source of industrially useful oils, for example as replacements for or improvements on mineral oils. Oil seeds, such as from rape, have a variety of lipids in them (Hildish & Williams, "Chemical Composition of Natural Lipids", Chapman Hall, London, 1964). There is now considerable interest in altering lipid composition by the use of recombinant DNA technology (Knauf, TIBtech, February 1987, 40-47), but by no means ail of the goals have been realised to date for a variety of reasons, in spite of the ever-increasing sophistication of the technology.

Success in tailoring the lipid content of plant-derived oils requires a firm understanding of the biochemistry and genes involved. Broadly, two approaches are available. First, plants may be modified to permit the synthesis of fatty acids which are new (for the plant); so, for example, laurate and/or stearate may be synthesised in rape. Secondly, the pattern and/or extent of incorporation of fatty acids into the glycerol backbone of the lipid may be altered. It is with this latter approach that the present invention is concerned, although the former approach may additionally be used.

Lipids are formed in plants by the addition of fatty acid moieties onto the glycerol backbone by a series of acyl transferase enzymes. There are three positions on the glycerol molecule at which fatty acid (acyl) moieties may be substituted, and the substitution reached at each position is catalysed by a position-specific enzyme: the enzymes are known as 1-, 2- and 3-acyltransferases, respectively.

One, but not the only, current aim of "lipid engineering" in plants is to provide oils including lipids with a high content of erucic (22:1) acid. Erucic acid-containing lipids are commercially desirable for a number of purposes, particularly as replacements to or supplements for mineral oils in certain circumstances, as alluded to above. In the case of oil seed rape (Brassica napus), one of the most significant oil producing crops in cultivation today, the specificity of the 2-acyltransferase enzyme positively discriminates against the incorporation of erucic acid at position 2. So, even in those cultivars of rape which are able to incorporate erucic acid at positions 1 and 3, where there is no (or at least reduced) discrimination against erucic acid, only a maximum 66% of the fatty acids incorporated into triacyl glycerols can be erucic acid. Such varieties of rape are known as HEAR (high erucic acid rape) varieties.

It would therefore be desirable to increase the erucic acid content of conventional oil seed rape, as well as HEAR varieties; the same can be said of oils of other vegetable oil crops such as maize, sunflower and soya, to name but a few examples. While in principle it may be thought possible to introduce into a desired plant DNA encoding a 2-acyltransferase of different fatty acid specificity, for example from a different plant, in practice there are a number of problems.

First, 2-acyltransferase and 3-acyltransferase are membrane bound, and therefore insoluble, enzymes. They have not been purified. This makes working with them difficult and rules out the use of many conventional DNA cloning procedures. This difficulty does not, paradoxically, lie in the way of cloning the gene (or at least cDNA) encoding the 1-acyltransferase enzyme, which is soluble: in fact, recombinant DNA work has already been undertaken on this enzyme for a completely different purpose, namely the enhancement of chilling resistance in tobacco plant leaves, by Murata et al (Nature 356 710-713 (1992)).

Secondly, very little is known about the 2- and 3-acyltransferases. There is no idea of their size or how they are targeted to membranes. No nucleotide or amino acid sequence data are available and no antibodies have been raised against them.

Although there has been discussion, therefore, of the desirability of modifying 2-acyltransferase specificity, for example by importing a gene coding for the corresponding enzyme, but of different specificity, from another species, there is a pressing need in the art for the key which enables this work to be done.

The present invention provides such a key, in the form of a DNA sequence (in the specific case, a cDNA sequence) encoding a 2-acyltransferase. The DNA sequence in FIGS. 1A-1C (SEQ ID NO: 1) from nucleotides 130 to 1254 encodes the 2-acyltransferase from maize (Zea mays), including the stop codon.

According to a first aspect of the invention, therefore, there is provided a recombinant or isolated DNA sequence, preferably encoding an enzyme having membrane-bound acyltransferase activity, and selected from: 1) encoding at least from MET.sub.1 to Stop.sub.375 (SEQ ID NO: 2) or its complementary strand, (SEQ ID NO: 1), or its complementary strand, under stringent conditions, and FIGS. 1A-1C (SEQ ID NO: 1)(SEQ ID NO: 10), or its complementary strand, but for the degeneracy of the genetic code.

Fragments of the above DNA sequences, for example of at least 15, 20, 30, 40 or 60 nucleotides in length, are also within the scope of the invention.

Suitable stringent conditions include salt solutions of approximately 0.9 molar at temperatures of from 35.degree. C. to 65.degree. C. More particularly, stringent hybridisation conditions include 6.times. SSC, 5.times. Denhardt's solution, 0.5% SDS, 0.5% tetrasodium pyrophosphate and 50 .mu.g/ml denatured herring sperm DNA; washing may be for 2.times.30 minutes at 65.degree. C. in 1.times. SSC, 0.1% SDS and 1.times.30 minutes in 0.2.times. SSC, 0.1% SDS at 65.degree. C.

Nucleic acid sequences within the scope of the first aspect of the invention will generally encode a protein having 2-acyltransferase activity, as that is the activity of the enzyme encoded by the nucleic acid sequence of FIGS. 1A-1C (SEQ ID NO: 1). Nucleic acid sequences not encoding a protein having enzymic activity (or the relevant enzymic activity) but otherwise conforming to the first aspect of the invention as set out above may be useful for other purposes (and are therefore also encompassed by the invention); for example they may be useful as probes, which is a utility shared by the nucleic acid sequences of the first aspect of the invention, including the FIG. 1 sequence itself.

The probe utility arises as follows. As there is likely to be a high degree of homology between acyltransferases of different species (and particularly between 2-acyltransferases of different species) the sequence of FIGS. 1A-1C (or part of it, or other sequences within the invention) may be used to probe cDNA or genomic libraries of other species in order to clone DNA sequences encoding acyltransferases having desired specificities. For example, if it is desired to produce oil having a high content of erucic acid esterified to glycerol, a DNA library of any species which naturally makes erucic acid may be probed. Suitable plants include meadow foam (Limnanthes spp., especially L. alba and, particularly, L. douglassi) and Crambe. Limnanthes douglassi is the preferred species, as specificity studies show that there is positive discrimination towards incorporation of erucic acid into position 2 of the triacylglyceride. Libraries of organisms other than the higher plants may be probed; for example, certain bacteria may have an acyltransferase of the desired specificity.

DNA in accordance with the invention will in general have a higher degree of homology with at least part of the sequence FIGS. 1A-1C (SEQ ID NO: 1) than with known sequences.

Recombinant DNA in accordance with the invention may be in the form of a vector, which may have sufficient regulatory sequences (such as a promoter) to direct expression. Vectors which are not expression vectors are useful for cloning purposes (as expression vectors themselves may be) . Host cells (such as bacteria and plant cells) containing vectors in accordance with the invention themselves form part of the invention.

DNA sequences in accordance with the invention can be used in another way in cloning a gene of interest from another species: if the DNA is coupled to a suitable promoter, for example on an expression vector in a suitable host organism, protein may be produced. Such protein may be used to generate polyclonal or monoclonal antibodies, or other binding molecules, which may then be used to screen for expression of homologous proteins in other species, for example as part of a DNA library screening programme.

Suitable CDNA libraries of.target species will generally be prepared when the gene of interest is likely to be expressed; so cDNA embryo libraries (prepared at the early lipid synthesis stage), for example of Limnanthes spp. will be preferred.

The invention therefore enables the cloning of a wide variety of genes (or, more generally, DNA sequences) encoding acyltransferases, and 2-acyltransferases in particular, using DNA sequences as described above.

Such acyltransferases, such as from Limnanthes spp. may also be cloned directly, for example using complementation studies, from a DNA library of the species in question. For example, if E. coli is used as the complementation host, a mutant is chosen which is defective in the relevant enzyme (for example 2-acyltransferase); the DNA library from the target species (such as L. douglassi) is cloned into the mutant complementation host; host cells incorporating the target acyltransferase gene in their genome can readily be selected using appropriate selective media. E. coli mutant JC201 is a suitable host for use in complementation studies relating to 2-acyltransferase.

Cloning the acyltransferase gene of choice into a microbial host, such as a bacterium like E. coli, in such a way that the gene can be expressed has a particularly advantage in that the substrate specificity of the acyltransferase gene can be assessed in the microbial host before transformed plants are prepared, thereby saving considerably on research time. Such an assessment may be made by competitive substrate assays, in which differently detectably labelled candidate substrates for the enzyme compete with each other for incorporation into the glyceride. For example, .sup.14 C-erucyl CoA and .sup.3 H-oleoyl CoA can be used as competitive substrates for 2-acyltransferase, and the relative amounts of .sup.14 C or tritium uptake into glyceride can be measured. (As 2-acyltransferases have acceptor, glycerol-based, substrates and donor, fatty acid-based, substrates, the experiment can be carried out with different acceptors, such as 1-erucyl-glycerol-3-phosphate and 1-oleoyl-glycerol-3-phosphate.) A gene coding for an enzyme which preferentially donates erucic acid to the acceptor (particularly 1-erucyl-glycerol-3-phosphate) may by this means be identified as a DNA sequence of choice for further use in the invention as described below.

In a second aspect of the invention, there is provided a plant having one or more insoluble acyltransferase enzymes having a substrate specificity which differs from the native enzyme of the plant.

While site-directed mutagenesis and/or other protein engineering techniques may be used to alter the specificity of an enzyme native to the plant, it is preferred that the plant be transgenic and incorporate an expressible acyltransferase gene encoding an enzyme of the desired specificity from another species. 2-acyltransferases are the enzymes of choice. For example, as described above, a 2-acyltransferase enzyme which has an enhanced specificity for, or at least no discrimination against, erucic acid, may be made by this means to express in a plant which would not normally incorporate erucic acid into triacylglycerides. An important embodiment of the invention relates to genetically engineered plants which have higher levels of erucic acid incorporated into triacylglycerols than in corresponding non-engineered plants. Preferable though this embodiment may be, though, the invention is not limited to the enhancement of erucic acid incorporation into glycerides: other acids may be desired in other circumstances.

For the acyltransferase transgene to be expressible, a promoter has to be operatively coupled to it. Because at the present state of the art it is difficult precisely to regulate the site of incorporation of a transgene into the host genome, it is preferred that the transgene be coupled to its promoter prior to transformation of the plant. Promoters useful in the invention may be temporal- and/or seed-specific, but there is no need for them to be so: constitutive promoters, such as the CaMV 35S promoter, may be in fact be preferred because they are usually strong promoters. Other tissues are unlikely to be adversely affected if the transgene encoding the acyltransferase enzyme is expressed in them, as the availability of the fatty acid CoA substrates is effectively limited to the seed.

The promoter-transgene construct, once prepared, is introduced into plant cells by any suitable means. The invention extends to such plant cells. Preferably, DNA is transformed into plant cells using a disarmed Ti-plasmid vector and carried by Agrobacterium by procedures known in the art, for example as described in EP-A-0116718 and EP-A-0270822. Alternatively, the foreign DNA could be introduced directly into plant cells using an electrical discharge apparatus. This method is preferred where Agrobacterium is ineffective, for example where the recipient plant is monocotyledonous. Any other method that provides for the stable incorporation of the DNA within the nuclear DNA of any plant cell of any species would also be suitable. This includes species of plant which are not currently capable of genetic transformation.

Preferably DNA in accordance with the invention also contains a second chimeric gene (a "marker" gene) that enables a transformed plant or tissue culture containing the foreign DNA to be easily distinguished from other plants or tissue culture that do not contain the foreign DNA. Examples of such a marker gene include antibiotic resistance (Herrera-Estrella et al, EMBO J. 2(6) 987-95 (1983) and Herrera-Estrella et al, Nature 303 209-13 (1983)), herbicide resistance (EP-A-0242246) and glucuronidase (GUS) expression (EP-A-0344029). Expression of the marker gene is preferably controlled by a second promoter which allows expression in cells other than the tapetum, thus allowing selection of cells or tissue containing the marker at any stage of regeneration of the plant. The preferred second promoter is derived from the gene which encodes the 35S subunit of Cauliflower Mosaic Virus (CaMV) coat protein. However any other suitable second promoter could be used.

A whole plant can be regenerated from a single transformed plant cell, and the invention therefore provides transgenic plants (or parts of them, such as propagating material) including DNA in accordance with the invention as described above. The regeneration can proceed by known methods.

In one embodiment of the invention, the transgenic plant's native acyltransferase gene which corresponds to the transgene may be rendered at least partially inoperative or removed. So, if the transgene encodes a 2-acyltransferase, the plant's native 2-acyltransferase may be rendered inoperative by, for example, antisense or ribozyme techniques, as is known in the art.

By means of the invention, plants generating oil with a tailored lipid content may be produced. For example, the lipid composition of triacylglycerides in a plant may be substantially altered to produce triacylglycerides with a desired fatty acid (for example erucic acid) content higher than has hitherto been possible. For example, oil seed rape (B. napus) may be transformed to produce oil whose triacylglyceride has an erucic acid content of over 70%.

It can readily be seen that plants with increased lipid levels may be produced by means of the invention. However, the invention is also useful for producing plants with decreased lipid levels, which may be desired if elevated protein and/or starch levels are required. Decreased lipid levels may be achieved by interfering with the proper functioning of a gene encoding a 2-acyltransferase, for example by antisense or ribozyme technology. (Such reduced-lipid plants may if desired be further engineered for higher protein and/or starch content, if wished.)

Promoters which naturally drive 2-acyltransferases may also be obtained by hybridisation and/or restriction and/or sequencing studies using the sequence of FIGS. 1A-1C.

The invention enables the production of protein encoded by DNA of the first aspect of the invention, should that be desired. The protein may be expressed by host cells harbouring DNA in the form of an expression vector. The protein, which may be an enzyme having 2-acyltransferase activity, may have an amino acid sequence which is identical to or homologous with the sequence of FIGS. 1A-1C (SEQ ID NO: 2). The degree of homology will generally be greater than that of known proteins, and may be at least 40, 50, 60, 70, 80, 90, 95 or 99%.

Preferred features of each aspect of the invention are as for each other aspect mutatis mutandis.

The invention is illustrated by the following examples. The examples refer to the accompanying drawings, in which:

FIGS. 1A-1C shows the cDNA sequence derived in Example 1 (SEQ ID NO: 1) and its derived protein sequence (SEQ ID NO: 2).

FIG. 2 shows a sequence alignment of part of the gene products of plsB (SEQ ID NO: 3) and plsC (SEQ ID NO: 4) with part of the sequence shown in FIGS. 1A-1C (SEQ ID NO: 5), showing a conserved motif. plsb is the E. coli sn-glycerol-3-phosphate acyltransferase gene and plsC the 1-acyl-sn-glycerol-3-phosphate acyltransferease gene of E. coli. Double points indicate exact matches between two sequences and a single point conservative amino acid substitutions. Stars indicate identical amino acids in all three sequences and residues conserved in two out of the three sequences are marked by a + symbol.

FIGS. 3A, 3B and 3C: Membrane phospholipids from E. coli strains were extracted into chloroform and separated by 2-dimensional thin layer chromatography. The first dimension (ascending) was developed using chloroform:methanol:water (65:25:4) and the second dimension (left to right) developed with chloroform:methanol:acetic acid (65:25:10). Phospholipids were visualised by autoradiography for 16 hours at -70.degree. C. using Fuji RX film. The E. coli strains used were (FIG. 3A): JC201 which carries a thermosensitive mutation in the 1-acyl-sn-glycerol-3-phosphate acyltransferase gene; (FIG. 3B): JC201 containing the plasmid pPLSC, which encodes the E. coli 1-acyl-sn-glycerol-3-phosphate acyltransferase gene; (FIG. 3C): JC201 containing the plasmid whose cDNA insert sequence is shown in FIGS. 1A-1C. LPA, lysophosphatidic acid; PE, phosphatidylethanolamine; CL, cardiolipin; PG, phosphatidylglycerol; PA, phosphatidic acid; O, origin. 20% of the .sup.32 P is incorporated in LPA in JC201 and all of the corresponding label is incorporated in PE in both of the other two strains.

FIG. 4: Acyltransferase assays were performed using .sup.32 P-labelled lysophosphatidic acid which had been extracted from the E. coli strain JC201 and oleoyl CoA as an acyl donor. Phospholipids present in the reaction mixtures were extracted into chloroform and separated using silica gel thin layer chromatography. Chloroform:methanol:acetic acid:water (25:15:4:2) was used to develop the plates. The phospholipids were visualised by autoradiography for 16 hours at -70.degree. C. using Fuji RX film. The E. coli strains used were: JC201 which carries a thermosensitive mutation in the 1-acyl-sn-glycerol-3-phosphate acyltransferase gene; JC201 containing the plasmid PPLSC which encodes the E. coli 1-acyl-sn-glycerol-3-phosphate acyltransferase gene; JC201 containing the plasmid whose maize cDNA insert sequence is shown in FIGS. 1A-1C. LPA, lysophosphatidic acid; PA, phosphatidic acid.

FIGS. 5A and 5B shows a comparison of the protein sequence shown in FIGS. 1A-1C (SEQ ID NO: 6) with that derived (SEQ ID NO: 7) from a B. napus seed cDNA insert which was isolated by DNA hybridisation to the maize cDNA sequence. The sequences were aligned with the FastA align program (1988). Double points signify identical amino acids and single points conservative amino acid substitutions.

Complementation studies using a maize cDNA expression library transferred into the E. coli mutant JC201 allowed the isolation of a plasmid encoding a 2-acyltransferase enzyme from maize. The cDNA insert of this plasmid is 1.6 kb in size, and includes a poly A tail of 70 bp. The insert was sequenced to give the data shown and translation of the sequence revealed the present of only one large open reading frame. This is shown on FIGS. 1A-1C with proposed start methionine and stop codon in bold print. The 2-acyltransferase is 374 amino acids in size and sequencing upstream of open reading from showed that the protein is expressed as part of a fusion protein in E. coli. This consists of 10 amino acids of the .beta.-galactosidase protein, 43 amino acids (shown in sequence) corresponding to the 5' untranslated region of the MRNA and the 374 amino acid protein. Protein sequence comparisons of the large open reading frame with the 2-acyltransferase of E. coli show little overall identity but there is a stretch of 80 residues which has a high level of conservative substitution and contains some amino acids that are conserved in the 2-acyltransferase, 1-acyltransferase and N-acetyl glucosamine acyltransferase of E. coli.

E. coli strains were grown in minimal medium containing .sup.32 P orthophosphate. Total glycerolipids were extracted into organic solvents and separated by 2D thin layer chromatography (FIG. 3) (Lysophosphatidic acid (LPA) is the substrate for 2-acyltransferase (2-AT)).

As can be seen in FIG. 3A, the accumulation of .sup.32 P-labelled LPA in the mutant JC 201 illustrates the absence of a fully functional 2-AT. Addition of a plasmid carrying either the native E. coli gene (FIG. 3B), or the maize clone given in FIGS. 1A-1C (FIG. 3C) restores 2-AT activity to the cells, allowing LPA to be removed and further metabolised. (Lysophosphatidic acid.)

These data indicate that the DNA sequence given in FIGS. 1A-1C codes for 2-AT.

The cDNA region specifying the protein sequence given in FIGS. 1A-1C was cloned into the E. coli overexpression vector pET11d (Studier et al, Meth. Enzymol. 185 60-89 (1990)). Increased 2-acyltransferase activity following induction of expression from the plasmid insert confirmed that the sequence in FIGS. 1A-1C is that of 2-AT.

2-acyltransferase assays were carried out using membranes isolated from the mutant strain JC.201 which lacks 2-AT and from JC.201 containing the maize plasmid (FIG. 4).

2-AT activity was not detected in membrane fractions from JC.201. The addition of a plasmid carrying the native E. coli gene or the sequence given in FIGS. 1A-1C (SEQ ID NO: 1), to JC.201 resulted in restoration of 2-AT activity to the membranes. rape

A seed cDNA library from Brassica napus was screened with the sequence given in FIGS. 1A-1C (SEQ ID NO: 1), using standard techniques (Sambrook et al "Molecular Cloning--A Laboratory Manual", 2nd Edition, Cold Spring Harbor Laboratory Press, 1989).

For the hybridisation of the maize cDNA insert to the rape library: hybridisation was in 6.times. SSC, 5.times. Denhardts solution, 0.5% SDS, 0.5% tetrasodium pyrophosphate and 50 ugml.sup.-1 denatured herring sperm DNA. The filters were washed 2.times.30 minutes at 65.degree. C. in 1.times. SSC, 0.1% SDS and 1.times.30 minutes in 0.2.times. SSC, 0.1% SDS at 65.degree. C.

A hybridising clone was sequenced and a protein sequence derived for the large ORF. Alignment of this protein sequence with that derived from the maize cDNA clone given in FIGS. 1A-1C (SEQ ID NO: 1), is shown in FIGS. 5A and 5B.

The strong identity between these sequences illustrates the potential of using the sequence given in FIGS. 1A-1C (SEQ ID NO: 1) to obtain other 2-ATS.

The sequence given in FIGS. 1A-1C (SEQ ID NO: 1) can be cloned, alongside a suitable promoter, into a suitable vector for expression in plants. The vector can be used to transform plants and the resulting plants expressing the 2-AT can be analysed for lipid content. Lipid metabolism is expected to be upregulated and elevated lipid levels were detectable in seeds.

The sequence given in FIGS. 1A-1C (SEQ ID NO: 1) may be cloned, alongside a suitable promoter, in the antisense orientation into a suitable vector for expression in plants. The vector can be used to transform plants and the resulting plants expressing the 2-AT can be analysed for protein and starch content. Elevated levels of starch and protein are expected to be detectable in seeds.

The DNA sequence of a 2-AT derived from L. douglassii (obtained as described in Example 5) can be introduced into oilseed rape (OSR) under the expression of a suitable promoter, using vectors and plant transformation methods well known in the art. A second sequence, comprising antisense or ribozymes against the rape cDNA (Example 5) can be introduced for simultaneous expression. The resultant transformed plant is expected to have 2-AT activity corresponding to that of L. douglassii, with concurrent down regulation of the native rape 2-AT gene.

The modified OSR plant thus obtained had higher levels of erucic acid in position 2 of its triacylglycerols than wild type plants. In addition higher levels of trierucin are found in the seed oil.

The sequence given in FIGS. 1A-1C (SEQ ID NO: 1) is used to screen a genomic library of Arabidopsis and a hybrid using clone obtained. Using standard techniques, a promoter may be derived from this clone. The promoter may be used to drive expression in plant cell membranes. SEQUENCE LISTING (1) GENERAL INFORMATION: (iii) NUMBER OF SEQUENCES: 7 (2) INFORMATION FOR SEQ ID NO: 1: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1514 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 130..1254 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1: CCCCGTCCTCCTCGTCGCCGGCGGAGCCGCCTACTATCGCCTGGAGAAGGAGCGCCGCGG60 GGAGCTTTTCCCACTGCCGACTGCCGTCTGACCCTCCGAGATCGGAAGCGGCGCCGGCGC120 CGGCCGGCGATGGCGATCCCGCTCGTGCTCGTCGTGCTCCCGCTCGGC168 MetAlaIleProLeuValLeuValValLeuProLeuGly 1510 CTGCTCTTCCTCCTGTCCGGCCTCATCGTCAACGCCATCCAGGCCGTC216 LeuLeuPheLeuLeuSerGlyLeuIleValAsnAlaIleGlnAlaVal 152025 CTATTTGTGACGATAAGGCCCTTTTCGAAGAGCTTCTACCGTCGGATC264 LeuPheValThrIleArgProPheSerLysSerPheTyrArgArgIle 30354045 AACAGATTCTTGGCCGAGCTGCTGTGGCTTCAGCTTGTCTGGGTGGTG312 AsnArgPheLeuAlaGluLeuLeuTrpLeuGlnLeuValTrpValVal 505560 GACTGGTGGGCAGGTGTTAAGGTACAACTGCATGCAGATGAGGAAACT360 AspTrpTrpAlaGlyValLysValGlnLeuHisAlaAspGluGluThr 657075 TACAGATCAATGGGTAAAGAGCATGCACTCATCATATCAAATCATCGG408 TyrArgSerMetGlyLysGluHisAlaLeuIleIleSerAsnHisArg 808590 AGTGATATTGATTGGCTCATTGGATGGATATTGGCCCAGCGTTCAGGG456 SerAspIleAspTrpLeuIleGlyTrpIleLeuAlaGlnArgSerGly 95100105 TGCCTTGGAAGTACACTTGCTGTCATGAAGAAGTCATCCAAGTTCCTT504 CysLeuGlySerThrLeuAlaValMetLysLysSerSerLysPheLeu 110115120125 CCAGTTATTGGCTGGTCAATGTGGTTTGCAGAGTACCTCTTTTTGGAA552 ProValIleGlyTrpSerMetTrpPheAlaGluTyrLeuPheLeuGlu 130135140 AGGAGCTGGGCCAAGGATGAAAAGACACTAAAGTGGGGTCTCCAAAGG600 ArgSerTrpAlaLysAspGluLysThrLeuLysTrpGlyLeuGlnArg 145150155 TTGAAAGACTTCCCTAGACCATTTTGGCTAGCTCTTTTCGTCGAGGGT648 LeuLysAspPheProArgProPheTrpLeuAlaLeuPheValGluGly 160165170 ACTCGCTTTACTCCAGCAAAGCTTCTCGCAGCTCAGGAATATGCGGCC696 ThrArgPheThrProAlaLysLeuLeuAlaAlaGlnGluTyrAlaAla 175180185 TCCCAGGGCTTACCGGCTCCTAGAAATGTACTTATTCCACGTACCAAG744 SerGlnGlyLeuProAlaProArgAsnValLeuIleProArgThrLys 190195200205 GGATTTGTATCTGCTGTAAGTATTATGCGAGATTTTGTTCCAGCCATT792 GlyPheValSerAlaValSerIleMetArgAspPheValProAlaIle 210215220 TATGATACAACTGTAATAGTCCCTAAAGATTCCCCTCAACCAACAATG840 TyrAspThrThrValIleValProLysAspSerProGlnProThrMet 225230235 CTGCGGATTTTGAAAGGGCAATCATCAGTGATACATGTCCGCATGAAA888 LeuArgIleLeuLysGlyGlnSerSerValIleHisValArgMetLys 240245250 CGTCATGCAATGAGTGAGATGCCAAAATCAGATGAGGATGTTTCAAAA936 ArgHisAlaMetSerGluMetProLysSerAspGluAspValSerLys 255260265 TGGTGTAAAGACATTTTTGTGGCAAAGGATGCCTTACTGGACAAGCAT984 TrpCysLysAspIlePheValAlaLysAspAlaLeuLeuAspLysHis 270275280285 TTGGCAACAGGCACTTTCGATGAGGAGATTAGACCTATTGGCCGTCCA1032 LeuAlaThrGlyThrPheAspGluGluIleArgProIleGlyArgPro 290295300 GTGAAATCATTGCTGGTGACCCTGTTCTGGTCGTGCCTCCTGCTGTTT1080 ValLysSerLeuLeuValThrLeuPheTrpSerCysLeuLeuLeuPhe 305310315 GGCGCCATCGAGTTCTTCAAGTGGACACAGCTTCTGTCGACGTGGAGG1128 GlyAlaIleGluPhePheLysTrpThrGlnLeuLeuSerThrTrpArg 320325330 GGTGTGGCGTTCACTGCCGCAGGGATGGCGCTTGTGACGGGTGTCATG1176 GlyValAlaPheThrAlaAlaGlyMetAlaLeuValThrGlyValMet 335340345 CATGTCTTCATCATGTTCTCCCAGGCTGAGCGGTCGAGCTCAGCCAGG1224 HisValPheIleMetPheSerGlnAlaGluArgSerSerSerAlaArg 350355360365 GCGGCACGGAACCGGGTCAAGAAGGAATGAAAAATGGAGGGTGGAGA1271 AlaAlaArgAsnArgValLysLysGlu 370375 TGAGGTTCTCGTGGGGTTTGTTATGGGCAACCTTCAAAAGGACTCTCCATTCATATTAGT1331 ATTAATTCATATATATGCAGCGCCAAATTCCAGACATTGATATGCTCTCAAATAGGATGT1391 TCTGCTCCCCTCTTGTATTTGTATGCAGGAAAGGGTTTGTAGGGAGTTTACCCCCCCCCC1451 CCCCCCCCCCGCCTTTCTTTGGGGAAGAAAGACATATTCTGGAAGCCTTCCAGTAGTTCA1511 AAA1514 (2) INFORMATION FOR SEQ ID NO: 2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 374 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: MetAlaIleProLeuValLeuValValLeuProLeuGlyLeuLeuPhe 151015 LeuLeuSerGlyLeuIleValAsnAlaIleGlnAlaValLeuPheVal 202530 ThrIleArgProPheSerLysSerPheTyrArgArgIleAsnArgPhe 354045 LeuAlaGluLeuLeuTrpLeuGlnLeuValTrpValValAspTrpTrp 505560 AlaGlyValLysValGlnLeuHisAlaAspGluGluThrTyrArgSer 65707580 MetGlyLysGluHisAlaLeuIleIleSerAsnHisArgSerAspIle 859095 AspTrpLeuIleGlyTrpIleLeuAlaGlnArgSerGlyCysLeuGly 100105110 SerThrLeuAlaValMetLysLysSerSerLysPheLeuProValIle 115120125 GlyTrpSerMetTrpPheAlaGluTyrLeuPheLeuGluArgSerTrp 130135140 AlaLysAspGluLysThrLeuLysTrpGlyLeuGlnArgLeuLysAsp 145150155160 PheProArgProPheTrpLeuAlaLeuPheValGluGlyThrArgPhe 165170175 ThrProAlaLysLeuLeuAlaAlaGlnGluTyrAlaAlaSerGlnGly 180185190 LeuProAlaProArgAsnValLeuIleProArgThrLysGlyPheVal 195200205 SerAlaValSerIleMetArgAspPheValProAlaIleTyrAspThr 210215220 ThrValIleValProLysAspSerProGlnProThrMetLeuArgIle 225230235240 LeuLysGlyGlnSerSerValIleHisValArgMetLysArgHisAla 245250255 MetSerGluMetProLysSerAspGluAspValSerLysTrpCysLys 260265270 AspIlePheValAlaLysAspAlaLeuLeuAspLysHisLeuAlaThr 275280285 GlyThrPheAspGluGluIleArgProIleGlyArgProValLysSer 290295300 LeuLeuValThrLeuPheTrpSerCysLeuLeuLeuPheGlyAlaIle 305310315320 GluPhePheLysTrpThrGlnLeuLeuSerThrTrpArgGlyValAla 325330335 PheThrAlaAlaGlyMetAlaLeuValThrGlyValMetHisValPhe 340345350 IleMetPheSerGlnAlaGluArgSerSerSerAlaArgAlaAlaArg 355360365 AsnArgValLysLysGlu 370 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: TyrPheValGluGlyGlyArgSerArgThrGlyArgLeuLeuAsp 151015 (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: MetPheProGluGlyThrArgSerArgGlyArgGlyLeuLeuPro 151015 (2) INFORMATION FOR SEQ ID NO: 5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5: LeuPheValGluGlyThrArgPheThrProAlaLysLeuLeuAla 151015 (2) INFORMATION FOR SEQ ID NO: 6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 374 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: MetAlaIleProLeuValLeuValValLeuProLeuGlyLeuLeuPhe 151015 LeuLeuSerGlyLeuIleValAsnAlaIleGlnAlaValLeuPheVal 202530 ThrIleArgProPheSerLysSerPheTyrArgArgIleAsnArgPhe 354045 LeuAlaGluLeuLeuTrpLeuGlnLeuValTrpValValAspTrpTrp 505560 AlaGlyValLysValGlnLeuHisAlaAspGluGluThrTyrArgSer 65707580 MetGlyLysGluHisAlaLeuIleIleSerAsnHisArgSerAspIle 859095 AspTrpLeuIleGlyTrpIleLeuAlaGlnArgSerGlyCysLeuGly 100105110 SerThrLeuAlaValMetLysLysSerSerLysPheLeuProValIle 115120125 GlyTrpSerMetTrpPheAlaGluTyrLeuPheLeuGluArgSerTrp 130135140 AlaLysAspGluLysThrLeuLysTrpGlyLeuGlnArgLeuLysAsp 145150155160 PheProArgProPheTrpLeuAlaLeuPheValGluGlyThrArgPhe 165170175 ThrProAlaLysLeuLeuAlaAlaGlnGluTyrAlaAlaSerGlnGly 180185190 LeuProAlaProArgAsnValLeuIleProArgThrLysGlyPheVal 195200205 SerAlaValSerIleMetArgAspPheValProAlaIleTyrAspThr 210215220 ThrValIleValProLysAspSerProGlnProThrMetLeuArgIle 225230235240 LeuLysGlyGlnSerSerValIleHisValArgMetLysArgHisAla 245250255 MetSerGluMetProLysSerAspGluAspValSerLysTrpCysLys 260265270 AspIlePheValAlaLysAspAlaLeuLeuAspLysHisLeuAlaThr 275280285 GlyThrPheAspGluGluIleArgProIleGlyArgProValLysSer 290295300 LeuLeuValThrLeuPheTrpSerCysLeuLeuLeuPheGlyAlaIle 305310315320 GluPhePheLysTrpThrGlnLeuLeuSerThrTrpArgGlyValAla 325330335 PheThrAlaAlaGlyMetAlaLeuValThrGlyValMetHisValPhe 340345350 IleMetPheSerGlnAlaGluArgSerSerSerAlaArgAlaAlaArg 355360365 AsnArgValLysLysGlu 370 (2) INFORMATION FOR SEQ ID NO: 7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 295 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7: MetAlaMetAlaAlaAlaValIleValProLeuGlyIleLeuPhePhe 151015 IleSerGlyLeuValValAsnLeuLeuGlnArgSerGlyCysLeuGly 202530 SerAlaLeuAlaValMetLysLysSerSerLysPheLeuProValIle 354045 GlyTrpSerMetTrpPheSerGluTyrLeuPheLeuGluArgAsnTrp 505560 AlaLysAspGluSerThrLeuLysSerGlyLeuGlnArgLeuAsnAsp 65707580 PheProArgProPheTrpLeuAlaLeuPheValGluGlyThrArgPhe 859095 ThrGluAlaLysLeuLysAlaAlaGlnGluTyrAlaAlaSerSerGlu 100105110 LeuProValProArgAsnValLeuIleProArgThrLysGlyPheVal 115120125 SerAlaValSerAsnMetArgSerPheValProAlaIleTyrAspMet 130135140 ThrValAlaIleProLysThrSerProProProThrMetLeuArgLeu 145150155160 PheLysGlyGlnProSerValValHisValHisIleLysCysHisSer 165170175 MetLysAspLeuProGluSerGluAspGluIleAlaGlnTrpCysArg 180185190 AspGlnPheValThrLysAspAlaLeuLeuAspLysHisIleAlaAla 195200205 AspThrPheAlaGlyGlnLysGluGlnAsnIleGlyArgProIleLys 210215220 SerLeuAlaValValLeuSerTrpAlaCysLeuLeuThrLeuGlyAla 225230235240 MetLysPheLeuHisTrpSerAsnLeuPheSerSerTrpLysGlyIle 245250255 AlaLeuSerAlaLeuGlyLeuGlyIleIleThrLeuCysMetGlnIle 260265270 LeuIleArgSerSerGlnSerGluArgSerThrProAlaLysValAla 275280285 ProAlaLysProLysAspAsn 290295 __________________________________________________________________________

## Claims

1. A recombinant or isolated nucleic acid molecule comprising a polynucleotide sequence selected from the group consisting of sequence in FIGS. 1A-1C (SEQ ID NO: 2) from about amino acid 1 to about amino acid 374 in SEQ ID NO: 2 the polypeptide having the amino acid sequence in FIGS. 1A-1C (SEQ ID NO: 2) from about amino acid 1 to about amino acid 374 in SEQ ID NO: 2; FIGS. 1A-1C (SEQ ID NO: 1) under stringent conditions; and is complementary to the nucleotide sequence in FIGS. 1A-1C (SEQ ID NO: 1) under stringent conditions.

2. The nucleic acid molecule according to claim 1, wherein said polynucleotide sequence encodes an enzyme having membrane-bound acyltransferase activity.

3. The nucleic acid molecule according to claim 2, wherein said acyltransferase activity is 2-acyltransferase activity.

4. A microbial host capable of expressing a polynucleotide according to claim 1.

5. A fragment of said polynucleotide according to claim 1 said fragment comprising at least 15 nucleotides.

6. A nucleotide sequence encoding an RNA, said RNA being in antisense orientation to the RNA encoded by the polynucleotide according to claim 1.

7. A method for making a recombinant vector comprising inserting an isolated nucleic acid molecule according to claim 1 into a vector.

8. The nucleic acid molecule according to claim 1, wherein said polynucleotide has the complete nucleotide sequence in FIGS. 1A-1C (SEQ ID NO: 1).

9. The nucleic acid molecule according to claim 1, wherein said polynucleotide has the nucleotide sequence in FIGS. 1A-1C (SEQ ID NO: 1) encoding the polypeptide having the amino acid sequence in FIGS. 1A-1C (SEQ ID NO: 2) from about amino acid 1 to about amino acid 375.

10. A recombinant vector produced by the method according to claim 7.

11. The recombinant vector according to claim 10, wherein said vector is an expression vector containing a promoter which drives the expression of said nucleic acid molecule.

12. A method of making a host cell containing a recombinant vector comprising introducing the recombinant vector according to claim 10 or 11 into a host cell.

13. A host cell produced by the method according to claim 12.